1. Home
  2. CXE vs UNCY Comparison

CXE vs UNCY Comparison

Compare CXE & UNCY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CXE
  • UNCY
  • Stock Information
  • Founded
  • CXE 1989
  • UNCY 2016
  • Country
  • CXE United States
  • UNCY United States
  • Employees
  • CXE N/A
  • UNCY N/A
  • Industry
  • CXE Investment Managers
  • UNCY Biotechnology: Pharmaceutical Preparations
  • Sector
  • CXE Finance
  • UNCY Health Care
  • Exchange
  • CXE Nasdaq
  • UNCY Nasdaq
  • Market Cap
  • CXE 110.0M
  • UNCY 91.0M
  • IPO Year
  • CXE N/A
  • UNCY 2021
  • Fundamental
  • Price
  • CXE $3.59
  • UNCY $4.95
  • Analyst Decision
  • CXE
  • UNCY Strong Buy
  • Analyst Count
  • CXE 0
  • UNCY 4
  • Target Price
  • CXE N/A
  • UNCY $63.75
  • AVG Volume (30 Days)
  • CXE 62.9K
  • UNCY 1.4M
  • Earning Date
  • CXE 01-01-0001
  • UNCY 08-13-2025
  • Dividend Yield
  • CXE 4.36%
  • UNCY N/A
  • EPS Growth
  • CXE N/A
  • UNCY N/A
  • EPS
  • CXE 0.07
  • UNCY N/A
  • Revenue
  • CXE N/A
  • UNCY N/A
  • Revenue This Year
  • CXE N/A
  • UNCY N/A
  • Revenue Next Year
  • CXE N/A
  • UNCY $1,458.53
  • P/E Ratio
  • CXE $51.00
  • UNCY N/A
  • Revenue Growth
  • CXE N/A
  • UNCY N/A
  • 52 Week Low
  • CXE $2.95
  • UNCY $2.02
  • 52 Week High
  • CXE $3.67
  • UNCY $11.00
  • Technical
  • Relative Strength Index (RSI)
  • CXE 64.76
  • UNCY 41.66
  • Support Level
  • CXE $3.51
  • UNCY $4.76
  • Resistance Level
  • CXE $3.56
  • UNCY $7.15
  • Average True Range (ATR)
  • CXE 0.03
  • UNCY 1.00
  • MACD
  • CXE 0.01
  • UNCY -0.23
  • Stochastic Oscillator
  • CXE 100.00
  • UNCY 6.87

About CXE MFS High Income Municipal Trust

Mfs High Income Municipal Trust is a United States-based diversified closed-end management investment company. Its investment objective is to seek high current income exempt from federal income tax. The fund invests a majority of its net assets, including assets attributable to preferred shares and borrowings for investment purposes, in tax-exempt bonds and tax-exempt notes.

About UNCY Unicycive Therapeutics Inc.

Unicycive Therapeutics Inc is a biotechnology company dedicated to developing treatments for certain medical conditions. It is focusing on kidney diseases. The company's manufactures drug, Renazorb, is a novel phosphate-binding agent being developed for the treatment of hyperphosphatemia. Unicycive's other drug, UNI-494, is a new chemical entity with the issued composition of matter patent protection in late preclinical development for the treatment of acute kidney injury. Company's pipeline comprised of two product candidates: Oxylanthanum Carbonate and UNI-494.

Share on Social Networks: